C. Selvais

AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy

S. Brichard, M. Abou-Samra, C. Selvais, 2020, Journal of cachexia, sarcopenia and muscle.

Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?

S. Brichard, M. Abou-Samra, C. Selvais, 2020, International journal of molecular sciences.

Walking down Skeletal Muscle Lane: From Inflammasome to Disease

S. Brichard, M. A. Davis-López de Carrizosa, M. Abou-Samra, 2021, Cells.

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy

M. A. Davis-López de Carrizosa, M. Abou-Samra, C. Selvais, 2022, International journal of molecular sciences.

AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers

I. Leclercq, S. Brichard, M. Nachit, 2022, Journal of cachexia, sarcopenia and muscle.

Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy

S. Brichard, M. A. Davis-López de Carrizosa, M. Abou-Samra, 2022, Frontiers in Immunology.

The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle

S. Brichard, P. V. D. Van den Bergh, M. A. Davis-López de Carrizosa, 2023, Cells.

Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending Shield

M. A. Davis-López de Carrizosa, M. Abou-Samra, C. Selvais, 2024, Antioxidants.